The development of preclinical models that closely resemble tumor biology changes during MT as well as HMP induced by TMZ in IDH-mutant glioma are crucial in advancing understanding of the underlying mechanisms and discovering new targets and factors of the disease. Here, IDH1 is linked to central nervous system cancer.